These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 11487273

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma.
    Inagaki H, Nagasaka T, Otsuka T, Sugiura E, Nakashima N, Eimoto T.
    Mod Pathol; 2000 May; 13(5):482-8. PubMed ID: 10824918
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Molecular diagnosis of synovial sarcoma: RT-PCR detection of SYT-SSX1/2 fusion transcripts in paraffin-embedded tissue.
    Tvrdík D, Povýsil C, Svatosová J, Dundr P.
    Med Sci Monit; 2005 Mar; 11(3):MT1-7. PubMed ID: 15735574
    [Abstract] [Full Text] [Related]

  • 9. SYT-SSX fusion genes in synovial sarcoma of the thorax.
    Yano M, Toyooka S, Tsukuda K, Dote H, Morimoto Y, Ohata N, Ichimura K, Aoe M, Date H, Shimizu N.
    Lung Cancer; 2004 Jun; 44(3):391-7. PubMed ID: 15140553
    [Abstract] [Full Text] [Related]

  • 10. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
    Izumi T, Oda Y, Hasegawa T, Nakanishi Y, Kawai A, Sonobe H, Takahira T, Kobayashi C, Yamamoto H, Tamiya S, Hirohashi S, Iwamoto Y, Tsuneyoshi M.
    Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
    [Abstract] [Full Text] [Related]

  • 11. Detection of SYT-SSX fusion transcripts in paraffin-embedded tissues of synovial sarcoma by reverse transcription-polymerase chain reaction.
    Wei Y, Wang J, Zhu X, Shi D, Hisaoka M, Hashimoto H.
    Chin Med J (Engl); 2002 Jul; 115(7):1043-7. PubMed ID: 12150740
    [Abstract] [Full Text] [Related]

  • 12. Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases.
    Coindre JM, Pelmus M, Hostein I, Lussan C, Bui BN, Guillou L.
    Cancer; 2003 Dec 15; 98(12):2700-7. PubMed ID: 14669292
    [Abstract] [Full Text] [Related]

  • 13. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome.
    Nilsson G, Skytting B, Xie Y, Brodin B, Perfekt R, Mandahl N, Lundeberg J, Uhlén M, Larsson O.
    Cancer Res; 1999 Jul 01; 59(13):3180-4. PubMed ID: 10397263
    [Abstract] [Full Text] [Related]

  • 14. Reverse transcription-polymerase chain reaction in situ hybridization for SYT-SSX fusion gene transcripts in synovial sarcomas.
    Kawauchi S, Fukuda T, Chochi Y, Kondo T, Oga A, Sasaki K.
    Int J Mol Med; 2005 Oct 01; 16(4):763-6. PubMed ID: 16142418
    [Abstract] [Full Text] [Related]

  • 15. Expression of stem cell factor and c-kit in human malignant fibrous histiocytoma cell line (TNMY1).
    Nakatani T, Marui T, Yamamoto T, Hitora T, Akisue T, Kawamoto T, Nagira K, Fujita I, Matsumoto K, Yoshiya S, Kurosaka M.
    Anticancer Res; 2003 Oct 01; 23(3B):2329-33. PubMed ID: 12894511
    [Abstract] [Full Text] [Related]

  • 16. KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes.
    Bellone G, Smirne C, Carbone A, Buffolino A, Scirelli T, Prati A, Solerio D, Pirisi M, Valente G, Nano M, Emanuelli G.
    Int J Oncol; 2006 Oct 01; 29(4):851-9. PubMed ID: 16964380
    [Abstract] [Full Text] [Related]

  • 17. Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.
    Antonescu CR, Kawai A, Leung DH, Lonardo F, Woodruff JM, Healey JH, Ladanyi M.
    Diagn Mol Pathol; 2000 Mar 01; 9(1):1-8. PubMed ID: 10718206
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of dysregulation of the receptor tyrosine kinases Kit, Flt3, and Met in histiocytic sarcomas of dogs.
    Zavodovskaya R, Liao AT, Jones CL, Yip B, Chien MB, Moore PF, London CA.
    Am J Vet Res; 2006 Apr 01; 67(4):633-41. PubMed ID: 16579756
    [Abstract] [Full Text] [Related]

  • 19. Molecular and immunohistochemical analyses of BCL2, KI-67, and cyclin D1 expression in synovial sarcoma.
    Krsková L, Kalinová M, Brízová H, Mrhalová M, Sumerauer D, Kodet R.
    Cancer Genet Cytogenet; 2009 Aug 01; 193(1):1-8. PubMed ID: 19602458
    [Abstract] [Full Text] [Related]

  • 20. [Demonstration of SYT-SSX11/2 fusion transcripts in synovial sarcomas using RT-PCR].
    Willeke F, Mechtersheimer G, Schwarzbach M, Weitz J, Lehnert T, Herfarth C, Otto HF, von Knebel Doeberitz M, Ridder R.
    Verh Dtsch Ges Pathol; 1998 Aug 01; 82():215-9. PubMed ID: 10095437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.